Insulin decreases hepatic glucose output in dogs regardless of whether it is administered systemically or intraportally.
Answers are grounded in this paper and cite their sources.
Insulin suppresses hepatic glucose output independently of route in dogs; leaves open translation to human physiology and diabetes management.
The effect of insulin on hepatic glucose metabolism was studied by a multiple-catheter technique in unanesthetized dogs with Eck fistula and with portacaval transposition. With the latter preparation, blood entering and leaving the liver was sampled from peripherally inserted catheters. In the unanesthetized Eck-fistula animals, insulin infusion produced a decrease in the hepatic glucose output. In the dogs with portacaval transposition, a constant infusion of insulin was given alternately by systemic and by intraportal routes. There was no significant difference between the effects of insulin administered by the two routes. During insulin infusion, glucose concentration differences across the liver were reduced, hepatic plasma flow was transiently elevated, and hepatic glucose output was decreased. After discontinuance of insulin, there was a transient rise of hepatic glucose output to above control values.
No takes yet. Share an insight, caveat, or question.
Starzl et al. (1965) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: